#pharma
articles
Health
GLP-1 Drugs Are Moving Far Beyond Weight Loss — and Rewriting Chronic Disease Treatment
New trial data link semaglutide and tirzepatide to improvements in sleep apnea, kidney, liver and heart outcomes, recast...
Health
India's Medicine QR Codes Must Move to Uniform Global Data Standards: GS1 CEO
As India extends QR codes to cancer drugs, narcotics, vaccines and antimicrobials, GS1 India's chief says standardised c...
Health
Ipsen’s Cabozantinib Offers New Option for Advanced Neuroendocrine Tumours After EU Approval
The targeted therapy, which blocks tumour growth, showed a 77% reduction in progression risk for pancreatic neuroendocri...
Companies
Lupin Q1 Profit Rises 16% as US Sales Surge; Stock Retreats from Day's High
Mumbai-based drugmaker Lupin beat estimates with a 16.1% rise in net profit to ₹1,415 crore, driven by a 30% jump in US ...
Companies
Deltha Pharma's Comeback: From Frozen Accounts and Lawsuits to 30% Annual Growth
Deltha Pharma CEO Maria Francesca Aceti explains how the Italian health group rebuilt after near-collapse, expanded abro...